Diabetic Neuropathies.
Elafros MA, Callaghan BC.
Continuum (Minneap Minn). 2023 Oct 1;29(5):1401-1417. doi: 10.1212/CON.0000000000001291.
Distal Symmetric Polyneuropathy: A Review.
Callaghan BC, Price RS, Feldman EL.
JAMA. 2015 Nov 24;314(20):2172-81. doi: 10.1001/jama.2015.13611.
Development and Progression of Polyneuropathy Over 5 Years in Patients With Type 2 Diabetes.
Brask-Thomsen PK, Itani M, Karlsson P, Kristensen AG, Krøigård T, Jensen TS, Tankisi H, Sindrup SH, Finnerup NB, Gylfadottir SS.
Neurology. 2024 Aug 13;103(3):e209652. doi: 10.1212/WNL.0000000000209652. Epub 2024 Jul 15.
Diabetic Polyneuropathy Early in Type 2 Diabetes Is Associated With Higher Incidence Rate of Cardiovascular Disease: Results From Two Danish Cohort Studies.
Bjerg L, Nicolaisen SK, Christensen DH, Nielsen JS, Andersen ST, Jørgensen ME, Jensen TS, Sandbæk A, Andersen H, Beck-Nielsen H, Sørensen HT, Witte DR, Thomsen RW, Charles M.
Diabetes Care. 2021 Jul;44(7):1714-1721. doi: 10.2337/dc21-0010. Epub 2021 May 26.
Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality.
Lapin BR, Pantalone KM, Milinovich A, Morrison S, Schuster A, Boulos F, Johnson K, Thakore NJ.
J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa394. doi: 10.1210/clinem/dgaa394.
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
Aso Y, Iijima T, Jojima T, Saito M, Tanuma D, Kase M, Sakurai S, Tomaru T, Usui I.
Postgrad Med. 2024 Apr;136(3):318-324. doi: 10.1080/00325481.2024.2347196. Epub 2024 Apr 29.
Cardiovascular autonomic neuropathy in patients with type 2 diabetes with and without sensorimotor polyneuropathy.
Peters E, Itani M, Kristensen AG, Terkelsen AJ, Krøigård T, Tankisi H, Jensen TS, Finnerup NB, Gylfadottir SS.
J Peripher Nerv Syst. 2023 Sep;28(3):450-459. doi: 10.1111/jns.12580. Epub 2023 Aug 14.
Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes.
Rumora AE, Guo K, Alakwaa FM, Andersen ST, Reynolds EL, Jørgensen ME, Witte DR, Tankisi H, Charles M, Savelieff MG, Callaghan BC, Jensen TS, Feldman EL.
Ann Clin Transl Neurol. 2021 Jun;8(6):1292-1307. doi: 10.1002/acn3.51367. Epub 2021 May 6.
Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
Xu J, Cai M, Wang Z, Chen Q, Han X, Tian J, Jin S, Yan Z, Li Y, Lu B, Lu H.
J Endocrinol Invest. 2023 May;46(5):869-882. doi: 10.1007/s40618-022-01929-w. Epub 2022 Oct 25.
Unraveling shared risk factors for diabetic foot ulcer: a comprehensive Mendelian randomization analysis.
Yin K, Qiao T, Zhang Y, Liu J, Wang Y, Qi F, Deng J, Zhao C, Xu Y, Cao Y.
BMJ Open Diabetes Res Care. 2023 Nov;11(6):e003523. doi: 10.1136/bmjdrc-2023-003523.
